Credit Suisse AG raised its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) by 2.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,230 shares of the company’s stock after buying an additional 1,181 shares during the period. Credit Suisse AG owned about 0.09% of Prestige Consumer Healthcare worth $2,770,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. BlackRock Inc. lifted its position in Prestige Consumer Healthcare by 12.4% during the first quarter. BlackRock Inc. now owns 9,115,718 shares of the company’s stock valued at $482,584,000 after buying an additional 1,004,337 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Prestige Consumer Healthcare by 0.6% during the third quarter. Vanguard Group Inc. now owns 5,647,622 shares of the company’s stock worth $281,421,000 after purchasing an additional 32,646 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Prestige Consumer Healthcare by 3.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,674,930 shares of the company’s stock worth $230,053,000 after purchasing an additional 116,613 shares in the last quarter. Macquarie Group Ltd. lifted its position in shares of Prestige Consumer Healthcare by 2.6% during the fourth quarter. Macquarie Group Ltd. now owns 1,972,000 shares of the company’s stock worth $123,447,000 after purchasing an additional 50,677 shares in the last quarter. Finally, State Street Corp lifted its position in shares of Prestige Consumer Healthcare by 1.2% during the third quarter. State Street Corp now owns 1,944,342 shares of the company’s stock worth $96,887,000 after purchasing an additional 22,886 shares in the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.
Prestige Consumer Healthcare Trading Up 0.1 %
PBH opened at $58.37 on Friday. The stock has a market capitalization of $2.89 billion, a PE ratio of -34.13, a P/E/G ratio of 1.73 and a beta of 0.58. The firm’s fifty day moving average price is $61.14 and its 200 day moving average price is $60.57. The company has a debt-to-equity ratio of 0.89, a current ratio of 2.66 and a quick ratio of 1.51. Prestige Consumer Healthcare Inc. has a 12-month low of $48.51 and a 12-month high of $68.54.
Insider Buying and Selling at Prestige Consumer Healthcare
In other Prestige Consumer Healthcare news, CEO Ronald M. Lombardi sold 32,800 shares of the business’s stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $65.57, for a total transaction of $2,150,696.00. Following the completion of the sale, the chief executive officer now owns 270,557 shares in the company, valued at $17,740,422.49. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is owned by insiders.
Wall Street Analyst Weigh In
PBH has been the topic of a number of recent research reports. StockNews.com initiated coverage on shares of Prestige Consumer Healthcare in a research report on Thursday, August 17th. They set a “buy” rating on the stock. 3M reissued a “reiterates” rating on shares of Prestige Consumer Healthcare in a research report on Monday, June 26th. Finally, TheStreet raised shares of Prestige Consumer Healthcare from a “c+” rating to a “b” rating in a report on Monday, August 7th. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $82.00.
Prestige Consumer Healthcare Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
- Five stocks we like better than Prestige Consumer Healthcare
- Find and Profitably Trade Stocks at 52-Week Lows
- MarketBeat Week in Review – 8/28 – 9/1
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- Which Wall Street Analysts are the Most Accurate?
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.